Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Margetuximab

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    MacroGenics Enters Agreement With TerSera For MARGENZA®
    MacroGenics Enters Agreement With TerSera For MARGENZA®

    22 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241022782206/en

    BUSINESSWIRE
    22 Oct 2024
    Share Share
    Zai Lab eyes imminent China filing for MacroGenics' HER2 drug
    Zai Lab eyes imminent China filing for MacroGenics' HER2 drug

    06 Oct 2021

    // Amber Tong ENDPTS

    https://endpts.com/unfazed-by-os-flop-zai-lab-eyes-imminent-china-filing-for-macrogenics-her2-drug/

    Amber Tong ENDPTS
    06 Oct 2021
    Share Share
    MacroGenics flips over an OS dud for Margenza in turnaround from earlier data
    MacroGenics flips over an OS dud for Margenza in turnaround from earlier data

    08 Sep 2021

    // K. Blankenship ENDPTS

    https://endpts.com/macrogenics-flips-over-an-os-dud-for-cancer-drug-margenza-in-surprising-turnaround-from-earlier-data/

    K. Blankenship ENDPTS
    08 Sep 2021
    Share Share
    MacroGenics Announces Lancet Oncology Publication of Margetuximab Data
    MacroGenics Announces Lancet Oncology Publication of Margetuximab Data

    10 Jul 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/07/09/2060324/0/en/MacroGenics-Announces-Lancet-Oncology-Publication-of-Margetuximab-Data-in-Gastric-Cancer.html#:~:text=(NASDAQ%3A%20MGNX)%2C%20a,pembrolizumab%20as%20a%20chemotherapy%2Dfree

    GLOBENEWSWIRE
    10 Jul 2020
    Share Share
    MacroGenics Announces Margetuximab Granted Orphan Drug Designation in the U.S.
    MacroGenics Announces Margetuximab Granted Orphan Drug Designation in the U.S.

    05 Jun 2020

    // PRESS RELEASE

    http://ir.macrogenics.com/news-releases/news-release-details/macrogenics-announces-margetuximab-granted-orphan-drug

    PRESS RELEASE
    05 Jun 2020
    Share Share
    MacroGenics Provides Update on FDA Review of Margetuximab for HER2-Positive MBC
    MacroGenics Provides Update on FDA Review of Margetuximab for HER2-Positive MBC

    28 May 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/05/28/2040109/0/en/MacroGenics-Provides-Update-on-FDA-Review-of-Margetuximab-for-HER2-Positive-Metastatic-Breast-Cancer.html

    GLOBENEWSWIRE
    28 May 2020
    Share Share